NCT03597620View on ClinicalTrials.gov

Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

October 31, 2020

Study Completion Date

December 13, 2022

Conditions
Psoriasis
Interventions
DRUG

Metaderm

Metaderm cream and spray will be apply to subjects scalp and body.

Trial Locations (1)

35249

Dermatology at the Whitaker Clinic, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03597620 - Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis | Biotech Hunter | Biotech Hunter